Teladoc Health (NYSE:TDOC) PT Lowered to $10.00

Teladoc Health (NYSE:TDOCFree Report) had its price target decreased by Truist Financial from $15.00 to $10.00 in a report published on Friday morning, Benzinga reports. Truist Financial currently has a hold rating on the health services provider’s stock.

Several other brokerages have also recently weighed in on TDOC. Wells Fargo & Company decreased their target price on Teladoc Health from $17.00 to $15.00 and set an equal weight rating for the company in a research note on Monday, April 29th. Canaccord Genuity Group decreased their price objective on Teladoc Health from $25.00 to $17.00 and set a buy rating for the company in a research report on Thursday. Bank of America decreased their price objective on Teladoc Health from $16.50 to $13.50 and set a neutral rating for the company in a research report on Tuesday, May 14th. TD Cowen decreased their price objective on Teladoc Health from $15.00 to $9.00 and set a hold rating for the company in a research report on Thursday. Finally, Evercore ISI cut their price target on Teladoc Health from $14.00 to $10.00 and set an in-line rating for the company in a research note on Tuesday, July 9th. Fourteen research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of Hold and an average target price of $14.44.

View Our Latest Report on Teladoc Health

Teladoc Health Stock Performance

Shares of TDOC traded down $0.29 during trading hours on Friday, reaching $7.66. 5,144,027 shares of the company’s stock traded hands, compared to its average volume of 5,461,081. The business’s fifty day simple moving average is $9.88 and its two-hundred day simple moving average is $13.61. Teladoc Health has a twelve month low of $7.31 and a twelve month high of $26.00. The firm has a market capitalization of $1.30 billion, a price-to-earnings ratio of -5.64 and a beta of 0.93. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74.

Insider Activity at Teladoc Health

In related news, Director Karen L. Daniel sold 9,834 shares of the company’s stock in a transaction dated Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total value of $117,024.60. Following the completion of the sale, the director now owns 36,995 shares in the company, valued at $440,240.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Over the last quarter, insiders sold 15,388 shares of company stock worth $178,225. 0.95% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TDOC. International Assets Investment Management LLC boosted its position in Teladoc Health by 1,777.0% during the fourth quarter. International Assets Investment Management LLC now owns 112,038 shares of the health services provider’s stock valued at $2,414,000 after purchasing an additional 106,069 shares during the last quarter. Sowell Financial Services LLC increased its stake in shares of Teladoc Health by 40.8% during the fourth quarter. Sowell Financial Services LLC now owns 18,907 shares of the health services provider’s stock worth $407,000 after purchasing an additional 5,475 shares during the period. Lecap Asset Management Ltd. bought a new position in shares of Teladoc Health during the fourth quarter worth approximately $1,530,000. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Teladoc Health by 15.6% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 56,181 shares of the health services provider’s stock worth $1,211,000 after buying an additional 7,583 shares in the last quarter. Finally, Quantum Private Wealth LLC grew its position in Teladoc Health by 68.6% during the fourth quarter. Quantum Private Wealth LLC now owns 41,637 shares of the health services provider’s stock worth $897,000 after buying an additional 16,937 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Further Reading

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.